Showing results (21-30 of 221) with videos related to
Sort By:
Pageof 23
Maturitas|November 1, 1993
Decrease of bone mineral density during estrogen substitution therapyS Rozenberg, R Gevers, A Peretz, et al.Obstetrics and Gynecology|September 1, 1997
Factors influencing the prescription of hormone replacement therapyS Rozenberg, M Kroll, J Vandromme, et al.Maturitas|July 29, 1999
Prescription attitudes among gynecologists towards two particular risk factors of osteoporosis: the patient's age and her bone mineral densityS Rozenberg, A Lefever, M Kroll, et al.JBR-BTR : Organe De La Societe Royale Belge De Radiologie (SRBR) = Orgaan Van De Koninklijke Belgische Vereniging Voor Radiologie (KBVR)|September 27, 2008
Current management of lobular in situ neoplasiaF Liebens, A S Cardinael, A P Schillings, et al.International Journal of Fertility and Menopausal Studies|January 1, 1995
Overview of the clinical usefulness of bone mineral measurements in the prevention of postmenopausal osteoporosisS Rozenberg, J Vandromme, M Kroll, et al.Journal of Endocrinological Investigation|December 1, 1992
Time related bias in longitudinal studies using dual photon absorptiometryS Rozenberg, J Vandromme, A Peretz, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1995
Precision and accuracy of in vivo bone mineral measurement in rats using dual-energy X-ray absorptiometryS Rozenberg, J Vandromme, J Neve, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 1, 1996
Bone sialoprotein expression in primary human breast cancer is associated with bone metastases developmentA Bellahcene, M Kroll, F Liebens, et al.La Revue Du Praticien|December 5, 2000
[Local and general anti-inflammatory treatment of common low back pain]S RozenbergEuropean Journal of Obstetrics, Gynecology, and Reproductive Biology|January 3, 2001
Clinical evidence supporting the rationale for constant oestrogen, intermittent progestogen hormone replacement therapyS RozenbergPageof 23